Remodeling of active endothelial enhancers is associated with aberrant gene-regulatory networks in pulmonary arterial hypertension

Pulmonary arterial hypertension (PAH) is a heterogeneous disease, causing severe breathing problems and cardiac morbidity. Here, the authors study chromatin marks in pulmonary arterial endothelial cells from PAH patients and controls and find changes in transcription factor and enhancer activity that suggest an aberrant response to signalling in PAH.

Abstract licence: CC BY-NC-ND

1. 8.

   Impact of artifact removal on ChIP quality metrics in ChIP-seq and ChIP-exo data · 2014

2. 24.

   Trimmomatic: a flexible trimmer for Illumina sequence data · 2014

3. 32.

   Genome-wide map of regulatory interactions in the human genome · 2014

4. 34.

   Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2 · 2014

5. 36.

   csaw: a Bioconductor package for differential binding analysis of ChIP-seq data using sliding windows · 2015

6. 59.

   Identification of rare sequence variation underlying heritable pulmonary arterial hypertension · 2018

7. 60.

   Genetic determinants of risk in pulmonary arterial hypertension: international genome-wide association studies and meta-analysis · 2019

60 more references, whose wording the paper’s licence keeps private.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.